The 2023 ASCO Gastrointestinal Cancers Symposium will host world-renowned experts in gastrointestinal cancers and this international scientific symposium allows for important interactions and exchanges between basic scientists and clinicians devoted to improved diagnosis and treatment of gastrointestinal cancers. Watch exclusive interviews from ASCO GI 2023 to keep up to date with the latest in gastrointestinal cancers!
View all videos

ASCO GI 2023

ASCO Gastrointestinal Cancers Symposium 2023
19–21 January 2023 | San Francisco, CA
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

#GDUGI2023 has wrapped!

http://VJOncology.com will have highlights of radiation therapy in borderline-resectable pancreatic cancer and more GI oncology from the final day of debates and updates ℹ️📽️

@GreatDebatesCME #CRCSM #PancSM #ESOCSM #STCSM #HPBCSM

Reply on Twitter 1642200195843735552Retweet on Twitter 1642200195843735552Like on Twitter 16422001958437355521Twitter 1642200195843735552
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

🎥 Andreas Dietz of @UniLeipzig discusses highlights from ECHNO 2023

Watch: 👉http://ow.ly/VOxt50NwT9M👈

@EHNSnews #ECHNO2023 #hncsm #HeadAndNeckCancer

Reply on Twitter 1642177541820633095Retweet on Twitter 1642177541820633095Like on Twitter 16421775418206330953Twitter 1642177541820633095
Retweet on TwitterVJ Oncology Retweeted
montypalSumanta K. Pal, MD, FASCO@montypal·
March 31, 2023

My dear friend & former coresident at @UCLA @datsunian put together this terrific summary for the @ASCO Daily News summarizing the link between ICIs & CVD. A critical message - plz read & pass along! @DrChoueiri @neerajaiims @avirupguha @CardioOncology @ACCinTouch @PGrivasMDPhD https://twitter.com/asco/status/1641533259103215616

ASCO@ASCO

[email protected] and @datsunian of @UCLAHealth explore the emerging link between immune checkpoint inhibitor cancer therapies and cardiovascular adverse events: https://fal.cn/3x11J #ASCODailyNews #CardioOnc

Reply on Twitter 1641796231939899392Retweet on Twitter 164179623193989939216Like on Twitter 164179623193989939252Twitter 1641796231939899392
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

This week's podcast is on highlights in #BreastCancer from St Gallen BCC 👩‍⚕️

Find out the latest in the use of chemotherapy, post-adjuvant therapy, clinical trial ethics, and more!

Listen here: 🎧http://ow.ly/encr50NwSWS

@DrLisaCarey @hoperugo @stolaney1 @lab_kok @KaidarOrit

Reply on Twitter 1642086945680392192Retweet on Twitter 1642086945680392192Like on Twitter 16420869456803921924Twitter 1642086945680392192
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

🚨 It’s the last day of #ELCC23 ! We’ll be bringing you the latest news on what experts have been discussing in #LungCancer as the event concludes!

Keep up-to-date at http://VJOncology.com

@VJOncology @myESMO #ELCC23 @OncoAlert #LCsm

Reply on Twitter 1642044272596643842Retweet on Twitter 1642044272596643842Like on Twitter 16420442725966438425Twitter 1642044272596643842
Load More

ASCO GI 2023

ASCO Gastrointestinal Cancers Symposium 2023
19–21 January 2023 | San Francisco, CA
The 2023 ASCO Gastrointestinal Cancers Symposium will host world-renowned experts in gastrointestinal cancers and this international scientific symposium allows for important interactions and exchanges between basic scientists and clinicians devoted to improved diagnosis and treatment of gastrointestinal cancers. Watch exclusive interviews from ASCO GI 2023 to keep up to date with the latest in gastrointestinal cancers!
View all videos
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

#GDUGI2023 has wrapped!

http://VJOncology.com will have highlights of radiation therapy in borderline-resectable pancreatic cancer and more GI oncology from the final day of debates and updates ℹ️📽️

@GreatDebatesCME #CRCSM #PancSM #ESOCSM #STCSM #HPBCSM

Reply on Twitter 1642200195843735552Retweet on Twitter 1642200195843735552Like on Twitter 16422001958437355521Twitter 1642200195843735552
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

🎥 Andreas Dietz of @UniLeipzig discusses highlights from ECHNO 2023

Watch: 👉http://ow.ly/VOxt50NwT9M👈

@EHNSnews #ECHNO2023 #hncsm #HeadAndNeckCancer

Reply on Twitter 1642177541820633095Retweet on Twitter 1642177541820633095Like on Twitter 16421775418206330953Twitter 1642177541820633095
Retweet on TwitterVJ Oncology Retweeted
montypalSumanta K. Pal, MD, FASCO@montypal·
March 31, 2023

My dear friend & former coresident at @UCLA @datsunian put together this terrific summary for the @ASCO Daily News summarizing the link between ICIs & CVD. A critical message - plz read & pass along! @DrChoueiri @neerajaiims @avirupguha @CardioOncology @ACCinTouch @PGrivasMDPhD https://twitter.com/asco/status/1641533259103215616

ASCO@ASCO

[email protected] and @datsunian of @UCLAHealth explore the emerging link between immune checkpoint inhibitor cancer therapies and cardiovascular adverse events: https://fal.cn/3x11J #ASCODailyNews #CardioOnc

Reply on Twitter 1641796231939899392Retweet on Twitter 164179623193989939216Like on Twitter 164179623193989939252Twitter 1641796231939899392
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

This week's podcast is on highlights in #BreastCancer from St Gallen BCC 👩‍⚕️

Find out the latest in the use of chemotherapy, post-adjuvant therapy, clinical trial ethics, and more!

Listen here: 🎧http://ow.ly/encr50NwSWS

@DrLisaCarey @hoperugo @stolaney1 @lab_kok @KaidarOrit

Reply on Twitter 1642086945680392192Retweet on Twitter 1642086945680392192Like on Twitter 16420869456803921924Twitter 1642086945680392192
VJOncologyVJ Oncology@VJOncology·
April 1, 2023

🚨 It’s the last day of #ELCC23 ! We’ll be bringing you the latest news on what experts have been discussing in #LungCancer as the event concludes!

Keep up-to-date at http://VJOncology.com

@VJOncology @myESMO #ELCC23 @OncoAlert #LCsm

Reply on Twitter 1642044272596643842Retweet on Twitter 1642044272596643842Like on Twitter 16420442725966438425Twitter 1642044272596643842
Load More

Catch up on highlights from ASCO GI 2023!

View all
1:07
KEYMAKER-U06 substudy 06A: favezelimab or MK-4380 in esophageal cancer
Ken Kato • 19 Jan 2023
1:19
29-month follow-up from CheckMate 648: nivolumab combination therapy in ESCC
Ken Kato • 19 Jan 2023
0:27
What to look out for at ASCO GI 2023
Changhoon Yoo • 19 Jan 2023
1:10
Predicting survival outcomes in colorectal cancer with the STING pathway
Heinz-Josef Lenz • 19 Jan 2023

Colorectal cancer

View all
1:10
Predicting survival outcomes in colorectal cancer with the STING pathway
Heinz-Josef Lenz • 19 Jan 2023
0:51
Addressing resistance to ICIs in colorectal cancer
Heinz-Josef Lenz • 19 Jan 2023
0:51
Key clinical trial updates from ASCO GI 2023
Rachna T. Shroff • 19 Jan 2023
2:42
PARADIGM: panitumumab versus bevacizumab in RAS-wt mCRC
Kohei Shitara • 19 Jan 2023

Genomic biomarkers in metastatic colorectal cancer

Gastroesophageal Cancer

View all
0:58
LB1908: a novel CAR-T cell therapy targeting claudin 18.2 in GI malignancies
David Bing Zhen • 19 Jan 2023
3:26
INFINTY: tremelimumab and durvalumab in MSI-high GC/GEJC
Filippo Pietrantonio • 19 Jan 2023
1:22
3-year follow-up of CheckMate 649: nivolumab + chemotherapy in GC/GEJC/EAC
Kohei Shitara • 19 Jan 2023
2:49
SPOTLIGHT: zolbetuximab and m-FOLFOX6 in CLDN18.2+, HER2- GEJ cancer
Kohei Shitara • 19 Jan 2023

Pancreatic cancer

View all
0:58
LB1908: a novel CAR-T cell therapy targeting claudin 18.2 in GI malignancies
David Bing Zhen • 19 Jan 2023
0:51
Key clinical trial updates from ASCO GI 2023
Rachna T. Shroff • 19 Jan 2023
0:43
daNIS-2: NIS793 with nab-paclitaxel and gemcitabine in mPDAC
Zev Wainberg • 20 Jan 2023
0:54
NAPOLI-3: first-line NALIRIFOX in metastatic pancreatic ductal adenocarcinoma
Zev Wainberg • 20 Jan 2023
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals